Clinical Trial Update: Creatine Safety & Tolerability in Huntington's Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the safety and tolerability of creatine in Huntington's disease has completed, with results posted in December 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• Creatine (creatine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Huntington's Disease (HD) | Phase 2 | Status: COMPLETED | Results posted: 2012-12-28